FDA Accepts AXSM's NDA Resubmission for Migraine Drug, Stock Up
Axsome Therapeutics, Inc · PHARMACEUTICAL PREPARATIONS · Now $234.48
+4.1% in 3d after detection
Post-detection moves
1h
—
1d
+1.7%
3d
+4.1%
7d
+3.4%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS